Novartis AG
SIX:NOVNEE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
SIX:NOVNEE
|
CH |
|
F
|
Fair Isaac Corp
SWB:FRI
|
US |
|
Secom Co Ltd
F:XSC
|
JP |
|
F
|
FIH Mobile Ltd
XMUN:FW3
|
TW |
|
Cementir Holding NV
OTC:CMTHF
|
IT |
|
Shinkin Central Bank
TSE:8421
|
JP |
|
FibroGen Inc
F:1FG0
|
US |
|
Industria de Diseno Textil SA
F:IXD1
|
ES |
|
D
|
DBS Group Holdings Ltd
XMUN:DEVL
|
SG |
Wall St Price Targets
NOVNEE Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOVNEE is 124.56 CHF with a low forecast of 92.01 CHF and a high forecast of 147.16 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOVNEE's stock price target?
Price Target
124.56
CHF
According to Wall Street analysts, the average 1-year price target for NOVNEE is 124.56 CHF with a low forecast of 92.01 CHF and a high forecast of 147.16 CHF.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
